Pictet Asset Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-19,055
Closed -$293K – 2130
2025
Q4
$293K Hold
19,055
– – ﹤0.01% 1728
2025
Q3
$189K Sell
19,055
-211,788
-92% -$2.2M ﹤0.01% 1894
2025
Q2
$2.29M Sell
230,843
-37,963
-14% -$400K ﹤0.01% 854
2025
Q1
$3.66M Buy
268,806
+255,190
+1,874% +$3.38M ﹤0.01% 839
2024
Q4
$174K Hold
13,616
– – ﹤0.01% 1884
2024
Q3
$152K Hold
13,616
– – ﹤0.01% 1887
2024
Q2
$153K Hold
13,616
– – ﹤0.01% 1826
2024
Q1
$169K Hold
13,616
– – ﹤0.01% 1802
2023
Q4
$190K Hold
13,616
– – ﹤0.01% 1762
2023
Q3
$201K Buy
+13,616
New +$192K ﹤0.01% 1686

Other funds holding DVAX

Pictet Asset Management's DVAX Position: Q1 2026 in Review

Pictet Asset Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 19,055 shares — an estimated $293K sold.

Pictet Asset Management first reported a position in DVAX in Q3 2023 and held it in 10 quarters. The position peaked at $3.66M in Q1 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Pictet Asset Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Pictet Asset Management sold 19,055 Dynavax Technologies shares in Q1 2026, an estimated $293K.
  • Pictet Asset Management first reported a position in Dynavax Technologies in Q3 2023 and held it in 10 quarters.
  • Pictet Asset Management's Dynavax Technologies position peaked at $3.66M in Q1 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.